Acciones Emergent Biosolutions Inc CINNOBER BOAT
Acciones
0IGA
US29089Q1058
Farmacéuticos
Ventas 2024 * | 1015,43 M 934 M | Ventas 2025 * | 1137,79 M 1046,98 M | Capitalización | 291 M 268 M |
---|---|---|---|---|---|
Resultado Neto 2024 * | -155 M -143 M | Resultado Neto 2025 * | -110 M -101 M | VE / Ventas 2024 * | 0,4 x |
Deuda neta 2024 * | 111 M 102 M | Deuda neta 2025 * | 336 M 309 M | VE / Ventas 2025 * | 0,55 x |
P/E ratio 2024 * |
-1,85
x | P/E ratio 2025 * |
-2,64
x | Empleados | - |
Rendimiento 2024 * |
-
| Rendimiento 2025 * |
-
| Flotante | 88,65 % |
Último transcript sobre Emergent Biosolutions Inc
Directores | Puesto | Edad | Desde |
---|---|---|---|
Joseph Papa
CEO | Chief Executive Officer | 68 | 21/02 |
Richard Lindahl
DFI | Director of Finance/CFO | 70 | 26/03/18 |
Kelly Warfield
CTO | Chief Tech/Sci/R&D Officer | - | 17/03/23 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Keith Katkin
BRD | Director/Board Member | 52 | 01/04/22 |
Marvin White
BRD | Director/Board Member | 61 | 01/06/10 |
Louis Sullivan
BRD | Director/Board Member | 90 | 01/01/05 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+32,09 % | 694 mil M | |
+29,39 % | 593 mil M | |
-1,34 % | 371 mil M | |
+20,34 % | 331 mil M | |
+7,39 % | 290 mil M | |
+14,25 % | 239 mil M | |
-3,03 % | 209 mil M | |
+10,02 % | 209 mil M | |
+8,49 % | 169 mil M |